Loading candles…
Dishman Carbogen Amcis Ltd operates in the pharmaceutical and specialty chemicals industries, providing contract research and manufacturing services as well as specialized pharmaceutical development and manufacturing. The company's business segments include Contract Research and Manufacturing Services (CRAMS) and Contract Development and Manufacturing Organization (CDMO). Its offerings encompass specialty chemicals, vitamins and chemicals, disinfectants, early-phase process research and development, late-stage clinical and commercial manufacturing, High Potent Active Pharmaceutical Ingredients (HiPo APIs), and Vitamin D analogues. With over 40 years of experience, Dishman Carbogen Amcis specializes in complex and challenging substances and maintains high-capacity manufacturing and research facilities. The company has a presence across multiple continents, including Switzerland, the UK, Europe, China, and other countries. No information on founders, key management, incorporation details, subsidiaries, or stock listings is provided.
This page is a live market overview for DISHMAN CARBO AMCIS LTD (DCAL) on the NSE. As a listed security, DISHMAN CARBO AMCIS LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for DCAL before placing trades on tick2trade.
As of the latest feed, DCAL last traded at ₹193.04 on NSE, down ₹1.62 (0.83%) from the previous close of ₹194.66. Today's session range is ₹191.65 – ₹196.97, against a 52-week band of ₹128.5 – ₹321.95. Traded volume today stands at 1.26L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for DCAL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether DCAL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for DISHMAN CARBO AMCIS LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in DCAL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated DCAL option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and other business matters | 19 May 2026 |
| Fund Raising | To consider Fund Raising | 18 Mar 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 3 Feb 2026 |
| Fund Raising | To consider Fund Raising | 27 Dec 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 4 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025, Fund Raising and other business matters | 12 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 21 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.